N. Scott Fine - 20 Oct 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CYTH
Reported as of: 20 Oct 2023
Net transaction value: +$175,150
SEC form: 4
Accepted by SEC: 23 Oct 2023, 06:05:03 UTC
Prior SEC filing: 24 Apr 2023
Next SEC filing: 05 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ N. Scott Fine

Key filing fact

N. Scott Fine filed Form 4 for Cyclo Therapeutics, Inc. (CYTH) on 23 Oct 2023.

Key facts

This page summarizes N. Scott Fine's Form 4 filing for Cyclo Therapeutics, Inc. (CYTH).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Oct 2023, 06:05.

Change

Previous filing in this sequence was filed on 24 Apr 2023.
Current net transaction value: +$175,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTH transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $212,575
Shares: +299,402
Change %: +67%
Price: $0.7100
Shares after: 743,804
Date: 20 Oct 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTH transaction Derivative

Warrant to Purchase Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $37,425
Shares: -299,402
Change %: -100%
Price: $0.1250
Shares after: 0
Date: 20 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 299,402
Exercise price: $0.7100

CYTH transaction Derivative

Warrant to Purchase Common Stock

Purchase

Transaction value
Shares: +329,342
Change %
Price
Shares after: 329,342
Date: 20 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 329,342
Exercise price: $0.9500
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.